Vanessa Taylor

Vanessa Taylor is the current Chief Scientific Officer at Terray Therapeutics, previously holding the title of VP of Biology at Rigel Pharmaceuticals Inc. Vanessa has extensive experience in preclinical small molecule drug development, with a focus on inflammatory and rare diseases. Throughout their career, Vanessa has held various leadership roles in immunology, contributing to the selection of promising IND candidates for different programs. Vanessa's educational background includes a PhD in Immunology from the University of Cambridge and a Bachelor's degree in Molecular Biology and Biochemistry from Durham University.